Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03681964

Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort

This study aims to evaluate the diagnosis performance of several item used for the classification, the diagnosis and the prognostic of pSS (primary Sjogren syndrome)

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, 29609, France

Location status: Recruiting

Location contact

Valerie Devauchelle

CONTACT

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with suspected pSS underwent a standardised evaluation

Exclusion criteria

  • Opposition of patient

Treatment and study plan

Primary outcomes

  1. classification criteria

    Time frame: Inclusion (Day 0)

    classification criteria at inclusion of patients with suspected primary Sjögren's syndrome (pSS) underwent with standardised evaluation

Study contacts

Contact information is provided by the study sponsor or research team.

Valerie Devauchelle, MD,PhD

CONTACT

[email protected]

33 (0) 2 98 34 72 64

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Acronym: DIApSS

Important dates

Study start
2015
Primary completion
2020
Study completion
2030
First posted
Sep 24, 2018
Registry last updated
Sep 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.